SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:oru-69420"
 

Sökning: onr:"swepub:oai:DiVA.org:oru-69420" > Does zero atrial fi...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004966naa a2200409 4500
001oai:DiVA.org:oru-69420
003SwePub
008181008s2017 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-694202 URI
024a https://doi.org/10.1093/ehjci/eux157.0012 DOI
040 a (SwePub)oru
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Björkenheim, Anna,d 1980-u Department of Cardiology, Örebro University Hospital, Örebro, Sweden4 aut0 (Swepub:oru)anbm
2451 0a Does zero atrial fibrillation burden after atrial fibrillation ablation mean that patients are free of symptoms?
264 c 2017-06-20
264 1b Oxford University Press,c 2017
338 a print2 rdacarrier
500 a 
520 a Introduction: Success of atrial fibrillation (AF) ablation is usually defined as freedom of AF, although symptomatic relief often is what the patient’s desire. After ablation the proportion of ‘silent’ AF increases and success based on symptomatic AF recurrence may be overestimated.Purpose: To investigate the symptomatology of patients who are truly free of AF after ablation.Methods: In 57 patients the symptomatology after AF ablation was assessed as perceived by the patient using a validated AF-specific symptom questionnaire (AF6) and the overall treatment effect (OTE), and as classified by the physician using the EHRA score, at baseline, 6, 12 and 24 months. The cardiac rhythm was continuously monitored by an implantable loop recorder throughout the 2-year follow-up.Results: At 6, 12 and 24 months 14 (26%), 23 (43%) and 23 (43%) patients had an AF burden 0% during the past 6 months, and 13 of them had an AF burden 0% during the entire 2 year follow-up. All patients reported ‘OTE better’ at all time-points. All patients were also classified into EHRA I at 6 months. Being completely free of AF for six months periods did not mean complete freedom of symptoms, but the median AF6 sum score was consistently low with a narrowing IQR over time, 0 (IQR 0-27), 0.5 (IQR 0-7) and 0 (IQR 0-11) at 6, 12 and 24 months. At 6 months 8/14 patients (57%) scored AF6=0, the others 6, 11, 26, 28, 30 and 46 points. At 12 months 13/23 patients (56%) scored AF6=0, the others 1,1,3,3,5,7,7,7,14 and 22 points. At 24 months 12/23 (52%) patients scored AF6=0, the others 1, 1, 2, 4, 9, 11, 17, 20, 24, 32 and 42 points. Among the AF6 items, ‘worry/anxiety due to AF’ was the most common, while ‘tiredness due to AF’ was the highest scoring item. In the patients with AF burden 0% during the entire 2-year follow-up all patients were improved in OTE and all patients were classified into EHRA class I at all times after ablation and the median AF6 sum score was 4 (IQR0-28), 0.5 (IQR 0-8) and 1 (0-5) at 6, 12 and 24 months after ablation.Conclusions: Sudden elimination of AF by ablation does not automatically eliminate all symptoms that the patients associated with AF, but all patients felt better and were classified in EHRA class I at all time-points. Less than a half of the patients at any time-point scored some symptoms, but the symptoms gradually decreased over time, especially between 6 and 12 months.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
700a Brandes, A.u Department of Cardiology, Odense University Hospital, Odense, Denmark4 aut
700a Magnuson, A.u Örebro University Hospital, Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden4 aut
700a Chemnitz, A.u Department of Cardiology, Odense University Hospital, Odense, Denmark4 aut
700a Svedberg, L.u Department of Cardiology, Örebro University Hospital, Örebro, Sweden4 aut
700a Edvardsson, N.u Sahlgrenska Academy at Sahlgrenska University Hospital, Göteborg, Sweden4 aut
700a Poçi, Dritan,d 1969-u Department of Cardiology, Örebro University Hospital, Örebro, Sweden4 aut0 (Swepub:oru)dnpi
710a Department of Cardiology, Örebro University Hospital, Örebro, Swedenb Department of Cardiology, Odense University Hospital, Odense, Denmark4 org
773t Europace, Supplementsd : Oxford University Pressg 19:Duppl. 3, s. iii264-iii264q 19:Duppl. 3<iii264-iii264x 1099-6044x 1749-365X
773t EP Europaced : Oxford University Pressg 19:Duppl. 3, s. iii264-iii264q 19:Duppl. 3<iii264-iii264x 1099-5129x 1532-2092
856u https://doi.org/10.1093/ehjci/eux157.001y Fulltext
856u https://academic.oup.com/europace/article-pdf/19/suppl_3/iii264/17903406/eux157.001.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-69420
8564 8u https://doi.org/10.1093/ehjci/eux157.001

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy